Ge LanSu- SmithKline and Pfizer establish the medicine company of AIDS jointly

Ge LanSu- SmithKline and Pfizer establish the medicine company of AIDS jointly
New York, April 16 (Xinhuanet) British Ge LanSu - SmithKline and American Pfizer announces on the 16th, will cooperate in establishing a new company, will specially develop and sell and resist the medicine of AIDS, expect in order to being less likely to make an investment in market of medicine to resist AIDS, obtain the leading advantage.
London of Britain -based plain Lan Ge - the intersection of SmithKline and Company have several medicine to resist AIDS sell at the market at present, among them the patents of some medicines will expire soon. And New York of U.S.A. -based Pfizer is researching and developing new medicine which is resisting AIDS.
According to joint statement that both sides release the same day, two company combine the intersection of AIDS and the intersection of medicine and relevant resource of its, it is estimated that finishes new company's setting up in the fourth quarter of this year.
This newly formed enterprise will grasp 11 kinds of AIDS medicines that can be sold on the market, it is estimated the expected global market share of occupying 19, is second only to the market share of the lucky scientific technical corporation of Germany of U.S.A.. At present, the drugmakers of Bristol-Myers Squibb Co., Abbott Laboratories, Merck Company,etc. all research and develop competing with sale in AIDS medicine too.
The market analyst thinks, the cooperation between the Ge 's shows, drugmaker's gradually centralized strength researches and develops several kinds of AIDS medicines especially at present, and pay more attention to controlling and researching and developing the cost, some rivals in the industry are nowadays seeking cooperation, in order to share risk and medicine and research and develop the cost.
|